65001-79-8 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
5-Chloro-4-fluoro-2-nitrophenol is utilized as a key intermediate in the synthesis of various pharmaceuticals and agrochemicals. Its unique structure allows it to be a versatile building block for the development of new drugs and pesticides, contributing to advancements in healthcare and agriculture.
Used in Environmental Analysis:
5-Chloro-4-fluoro-2-nitrophenol serves as a reagent for the determination of copper in environmental water samples. Its ability to selectively react with copper ions makes it a valuable tool for environmental monitoring and ensuring water quality.
Used in Medical Applications:
Due to its antibacterial and antifungal properties, 5-Chloro-4-fluoro-2-nitrophenol is effective in certain medical applications. It can be used in the development of antimicrobial agents to combat infections caused by bacteria and fungi, contributing to public health and disease prevention.
Used in Agricultural Applications:
5-Chloro-4-fluoro-2-nitrophenol's antimicrobial properties also make it suitable for use in agriculture. It can be incorporated into fungicides and bactericides to protect crops from diseases and pests, thereby increasing crop yields and ensuring food security.
However, it is crucial to handle 5-Chloro-4-fluoro-2-nitrophenol with caution due to its potential toxicity and environmental impact. Proper safety measures and disposal methods should be followed to minimize any adverse effects on human health and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 65001-79-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,0,0 and 1 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 65001-79:
(7*6)+(6*5)+(5*0)+(4*0)+(3*1)+(2*7)+(1*9)=98
98 % 10 = 8
So 65001-79-8 is a valid CAS Registry Number.
65001-79-8Relevant academic research and scientific papers
Al-Harthy, Thuraya,Zoghaib, Wajdi Michel,Pflüger, Maren,Sch?pel, Miriam,?nder, Kamil,Reitsammer, Maria,Hundsberger, Harald,Stoll, Raphael,Abdel-Jalil, Raid
, (2016)
To design new compounds suitable as starting points for anticancer drug development, we have synthesized a novel series of benzoxazoles with pharmaceutically advantageous piperazine and fluorine moieties attached to them. The newly synthesized benzoxazoles and their corresponding precursors were evaluated for cytotoxicity on human A-549 lung carcinoma cells and non-cancer HepaRG hepatocyes. Some of these new benzoxazoles show potential anticancer activity, while two of the intermediates show lung cancer selective properties at low concentrations where healthy cells are unaffected, indicating a selectivity window for anticancer compounds.
